How Do Anabolic Steroids Work? The Mechanism From Receptor to Muscle Cell

If you have ever wondered how anabolic steroids actually build muscle, the answer begins inside the cell, at a protein called the androgen receptor. Every effect you experience on a steroid cycle, from increased strength to acne to mood changes, traces back to what happens when a steroid molecule binds to that receptor and triggers a cascade of gene expression changes that alter how your body builds and breaks down tissue.

What happens when an anabolic steroid enters a muscle cell?

Anabolic steroids are synthetic derivatives of testosterone. Because they are lipophilic (fat-soluble), they pass through cell membranes without needing a transporter. Once inside the cell cytoplasm, the steroid molecule binds to the androgen receptor (AR), a ligand-activated transcription factor that sits dormant in the cytoplasm, held in an inactive state by heat shock proteins (HSPs).

When the steroid binds to the AR, the heat shock proteins dissociate, the receptor changes shape (a process called conformational change), and the steroid-AR complex forms a dimer, meaning two steroid-receptor units pair together. This dimer is then transported into the cell nucleus through nuclear pore complexes via importin-mediated translocation (Davey and Bhatt, 2020).

Inside the nucleus, the AR dimer binds to specific DNA sequences called androgen response elements (AREs). This binding recruits co-activator proteins, including CREB-binding protein (CBP)/p300 and steroid receptor coactivators (SRC-1, SRC-2, SRC-3), which together initiate transcription of target genes. The result is an increase in messenger RNA (mRNA) production, which is then translated by ribosomes into new proteins (Durzynska et al., 2022).

In skeletal muscle cells, the primary proteins being synthesised are contractile proteins: actin and myosin. This is the molecular basis of muscle growth. More mRNA means more protein production, and more contractile protein means larger, stronger muscle fibres.

How do anabolic steroids increase muscle protein synthesis?

The increase in muscle protein synthesis (MPS) is the central mechanism behind steroid-driven muscle growth. Under normal physiological conditions, your muscles exist in a dynamic equilibrium between protein synthesis and protein breakdown (proteolysis). Muscle growth occurs when synthesis exceeds breakdown over time.

Anabolic steroids shift this balance in two directions simultaneously. On the synthesis side, the enhanced gene transcription described above directly increases the rate at which muscle cells produce new proteins. On the breakdown side, androgens suppress the expression of genes involved in muscle catabolism, particularly MAFbx (muscle atrophy F-box, also called atrogin-1) and MuRF1, two ubiquitin ligases that tag muscle proteins for degradation (Basualto-Alarcon et al., 2013).

This dual action, increasing synthesis while reducing breakdown, is why anabolic steroids produce such pronounced effects on muscle mass. A 2020 review in Reviews in Endocrine and Metabolic Disorders described this as “exponentially amplifying protein transcription while simultaneously halting cellular degradation,” noting that the effect operates through both genomic pathways (gene transcription changes) and non-genomic pathways (rapid signalling cascades that bypass the nucleus) (Barbosa Neto et al., 2020).

What is the difference between anabolic and androgenic effects?

Every anabolic steroid produces two categories of effect. Anabolic effects are the tissue-building actions: increased muscle mass, enhanced bone mineral density, increased red blood cell production, and improved nitrogen retention. Androgenic effects are the masculinising actions: deepening of the voice, facial and body hair growth, increased sebum production (leading to acne), prostate stimulation, and androgenic alopecia (male pattern hair loss).

Both categories of effect are mediated by the same androgen receptor. The reason different steroids have different ratios of anabolic to androgenic activity is not because they bind to different receptors, but because of how they are metabolised in different tissues by two key enzymes: 5-alpha reductase and aromatase.

How does 5-alpha reductase determine whether a steroid is androgenic?

5-alpha reductase is an enzyme expressed primarily in the skin, prostate, scalp, liver and seminal vesicles. It converts testosterone into dihydrotestosterone (DHT), which is approximately three to five times more potent at the androgen receptor than testosterone itself. This amplification is why testosterone produces strong androgenic effects in tissues where 5-alpha reductase is present: the prostate grows, the scalp loses hair (in genetically susceptible individuals), and the sebaceous glands produce excess oil (Swerdloff et al., 2017).

However, in skeletal muscle, 5-alpha reductase activity is minimal. Testosterone itself, rather than DHT, is the primary active androgen in muscle tissue. This is why blocking 5-alpha reductase with drugs like finasteride reduces androgenic side effects (hair loss, prostate growth) without significantly reducing the anabolic (muscle-building) effects of testosterone.

Different synthetic steroids interact with 5-alpha reductase in different ways. Nandrolone (the active compound in Deca-Durabolin), for example, is actually reduced by 5-alpha reductase into a less potent metabolite (dihydronandrolone), rather than a more potent one. This is why Nandrolone has a high anabolic-to-androgenic ratio: it is potent in muscle (where 5-alpha reductase is not amplifying it) but relatively mild in skin and prostate (where 5-alpha reductase is reducing its potency). Compounds derived from DHT, such as Oxandrolone (Anavar), Stanozolol (Winstrol) and Drostanolone (Masteron), cannot be further reduced by 5-alpha reductase because they are already in their fully reduced form, which gives them predictable androgenic profiles.

How does aromatase convert steroids to oestrogen?

Aromatase (CYP19A1) is the enzyme that converts androgens into oestrogens. Specifically, it converts testosterone into oestradiol (the most potent natural oestrogen) and androstenedione into oestrone. Aromatase is expressed primarily in adipose tissue, but also in the brain, bone, liver, breast tissue and gonads.

Aromatisation is relevant to steroid users because supraphysiological doses of aromatisable compounds (principally testosterone and its derivatives, as well as Dianabol) produce supraphysiological levels of oestradiol. Elevated oestradiol is responsible for water retention (via aldosterone and antidiuretic hormone upregulation), gynaecomastia (breast tissue proliferation via oestrogen receptor activation in ductal tissue), and mood changes.

Steroids derived from DHT (Anavar, Winstrol, Masteron, Proviron) do not aromatise because the structural modification that makes them DHT derivatives also prevents the aromatase enzyme from acting on them. Trenbolone does not aromatise either, despite being a 19-nor compound. Nandrolone aromatises at approximately 20% the rate of testosterone, making it mildly oestrogenic but far less so than testosterone at equivalent doses.

Understanding aromatisation is essential for managing side effects on cycle. Aromatase inhibitors (AIs) such as Anastrozole work by blocking the aromatase enzyme, reducing the conversion of testosterone to oestradiol. However, oestrogen is not entirely undesirable: it plays important roles in bone density maintenance, lipid metabolism, cognitive function and libido. Crashing oestrogen with excessive AI use creates its own set of problems, which is why bloodwork-guided dosing is critical.

What are the non-genomic effects of anabolic steroids?

Not all steroid effects operate through the classical genomic pathway (AR binding, nuclear translocation, gene transcription). Some effects occur within seconds to minutes, far too quickly to be explained by gene transcription, which typically takes hours. These are called non-genomic effects.

Non-genomic androgen signalling involves steroid interaction with membrane-bound androgen receptors (mARs) or with other membrane proteins such as the sex hormone-binding globulin receptor (SHBG-R). These interactions activate intracellular signalling cascades including the MAPK/ERK pathway, the PI3K/Akt pathway, and calcium ion influx, all of which influence cell growth, survival and differentiation independently of gene transcription (Basualto-Alarcon et al., 2013).

Non-genomic effects are thought to contribute to the rapid strength increases that some users experience within the first week of a cycle, before significant new muscle tissue has been synthesised. They may also contribute to the neurological effects of steroids: aggression, confidence, libido changes and mood alterations likely involve rapid signalling in the central nervous system rather than slow genomic changes in muscle cells.

How do anabolic steroids affect satellite cells and muscle repair?

Satellite cells are muscle stem cells that sit between the muscle fibre membrane (sarcolemma) and the basal lamina. When muscle is damaged, whether by resistance training or injury, satellite cells are activated: they proliferate, differentiate into myoblasts, and fuse with existing muscle fibres or with each other to form new fibres. This process, called myonuclear addition, is essential for muscle hypertrophy because each myonucleus can only support a finite volume of cytoplasm (the “myonuclear domain” concept).

Androgens directly stimulate satellite cell activation and proliferation through AR-dependent signalling. A 2023 study published on bioRxiv demonstrated that the androgen receptor in mesenchymal progenitor cells (a population distinct from satellite cells but critical for muscle maintenance) regulates skeletal muscle mass via IGF-1 expression, suggesting that the anabolic effects of androgens on muscle involve signalling between multiple cell types, not just direct action on the muscle fibre itself (Oki et al., 2023).

This satellite cell activation is one reason why steroid users can train with higher volume and frequency: the increased repair capacity allows faster recovery from training-induced muscle damage. It is also why some of the muscle size gained on a steroid cycle is genuinely permanent: new myonuclei, once added, persist even after the steroid is discontinued, giving rise to “muscle memory” that allows faster regain of lost size in subsequent training blocks.

Why do different steroids produce different results?

If all anabolic steroids work through the same androgen receptor, it is reasonable to ask why Trenbolone produces different effects from Anavar, or why Testosterone feels different from Nandrolone. The answer lies in the combination of: binding affinity for the AR (some steroids bind more tightly and for longer), metabolic fate (5-alpha reduction, aromatisation, or neither), interaction with other steroid receptors (progesterone receptor binding by 19-nor compounds, glucocorticoid receptor antagonism by some steroids), and tissue-specific enzyme expression.

Trenbolone, for example, binds to the androgen receptor with approximately five times the affinity of testosterone and does not aromatise, but it also binds to the progesterone receptor, which explains its unique side effect profile (prolactin-related issues, insomnia, “Tren cough”). Anavar has a relatively low AR binding affinity but is resistant to both 5-alpha reduction and aromatisation, giving it a mild, predictable profile with minimal androgenic and oestrogenic sides. Testosterone is the most versatile because it is the endogenous hormone: your body has evolved to process it through every relevant metabolic pathway.

Understanding these mechanisms is the foundation for making informed decisions about compound selection, dose, ancillary use, and post-cycle therapy. Every topic covered in the Hemi Pharma UK blog library, from Anavar side effects to Proviron and SHBG, connects back to the receptor-level pharmacology explained here. For verified, independently tested compounds, all Hemi Pharma lab results are published before sale.

Frequently Asked Questions

How quickly do anabolic steroids start working?

The genomic effects of anabolic steroids, meaning the gene transcription changes that drive increased muscle protein synthesis, begin within hours of the first dose but take days to weeks to produce visible results. Most users notice strength increases within the first one to two weeks, with measurable changes in body composition becoming apparent by week three to four. Non-genomic effects such as mood, libido and confidence changes can occur within days. The speed of onset also depends on the ester attached to the steroid: short esters like propionate and acetate reach peak blood levels faster than long esters like enanthate and decanoate.

Do all steroids build muscle through the same mechanism?

All anabolic steroids exert their primary muscle-building effect through the same androgen receptor. The differences between compounds arise from their metabolic fate (whether they are converted to DHT, oestradiol, or remain unchanged), their binding affinity for the AR, and their interactions with other receptors such as the progesterone receptor or the glucocorticoid receptor. These differences explain why each steroid has a distinct profile of anabolic potency, androgenic side effects, and ancillary effects such as water retention or mood changes.

Can you build muscle without steroids?

Yes. Natural testosterone production, combined with resistance training and adequate nutrition, drives muscle protein synthesis through exactly the same androgen receptor pathway described in this article. Anabolic steroids amplify this pathway by providing supraphysiological androgen levels, but they are not the only way to activate it. The natural limit of muscle growth is determined by your genetics, training quality, nutritional intake and endogenous hormone levels.

Why do some steroids cause hair loss and others do not?

Hair loss from anabolic steroids is mediated by androgenic activity at the hair follicle. Steroids that are converted to DHT by 5-alpha reductase (principally testosterone) or that are already DHT derivatives (Winstrol, Masteron, Proviron) are the most likely to accelerate male pattern baldness in genetically susceptible individuals. Compounds like Nandrolone, which is converted to a less androgenic metabolite in the scalp, are less likely to cause hair loss. Anavar has a low androgenic rating and is generally considered one of the milder compounds for hair.

What does the anabolic-to-androgenic ratio mean?

The anabolic-to-androgenic ratio is a laboratory measure comparing a steroid’s muscle-building effect to its masculinising effect, with testosterone set as the baseline at 100:100. A steroid rated at 400:20 (like Anavar) has four times the anabolic potency per milligram but only one-fifth the androgenic potency. These ratios are derived from animal assays (the Hershberger assay, measuring levator ani muscle growth versus prostate growth in castrated rats) and do not translate directly to human experience, but they provide a useful relative comparison between compounds.

Shopping Basket
Scroll to Top